BVF INC/IL - FORWARD PHARMA A/S ownership

FORWARD PHARMA A/S's ticker is FWP and the CUSIP is 34986J105. A total of 24 filers reported holding FORWARD PHARMA A/S in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
BVF INC/IL ownership history of FORWARD PHARMA A/S
ValueSharesWeighting
Q4 2019$6,008,000
-9.1%
925,724
-85.7%
0.46%
-34.3%
Q3 2019$6,610,000
-24.3%
6,480,079
-23.6%
0.69%
-27.3%
Q2 2019$8,734,000
-12.7%
8,480,0790.0%0.95%
-14.8%
Q1 2019$10,006,000
+51.3%
8,480,0790.0%1.12%
+29.6%
Q4 2018$6,614,000
-65.9%
8,480,079
-0.3%
0.86%
-49.3%
Q3 2018$19,387,000
-16.2%
8,502,925
-0.0%
1.70%
-24.5%
Q2 2018$23,129,000
+124.1%
8,503,425
+78.8%
2.26%
+115.8%
Q1 2018$10,319,000
-18.4%
4,755,117
+37.6%
1.05%
-31.4%
Q4 2017$12,646,000
+47.5%
3,455,117
+137.4%
1.52%
+39.9%
Q3 2017$8,571,000
-69.6%
1,455,117
+4.8%
1.09%
-75.1%
Q2 2017$28,215,000
-5.7%
1,387,8530.0%4.38%
-13.9%
Q1 2017$29,908,000
+43.6%
1,387,8530.0%5.09%
+21.6%
Q4 2016$20,832,000
-28.5%
1,387,8530.0%4.18%
-23.8%
Q3 2016$29,145,000
+12.6%
1,387,853
-2.6%
5.49%
-0.4%
Q2 2016$25,885,000
+5.6%
1,424,611
-1.2%
5.52%
-9.0%
Q1 2016$24,502,000
-10.5%
1,441,2870.0%6.06%
+29.9%
Q4 2015$27,384,000
+14.4%
1,441,287
+41.8%
4.67%
-3.5%
Q3 2015$23,945,000
-37.6%
1,016,324
+0.7%
4.84%
-28.6%
Q2 2015$38,392,000
+15.1%
1,008,981
-14.3%
6.78%
-2.8%
Q1 2015$33,346,000
+52.1%
1,177,481
+11.9%
6.97%
+63.5%
Q4 2014$21,921,0001,052,3814.26%
Other shareholders
FORWARD PHARMA A/S shareholders Q3 2016
NameSharesValueWeighting ↓
BVF INC/IL 1,455,117$8,571,0001.09%
Baupost Group 6,463,265$39,232,0000.49%
Newtyn Management, LLC 268,903$1,584,0000.26%
Assured Investment Management LLC 1,475,612$7,383,0000.15%
Freedom Investment Management, Inc. 76,867$467,0000.03%
NJ State Employees Deferred Compensation Plan 10,000$59,0000.01%
TWO SIGMA SECURITIES, LLC 14,331$84,0000.01%
HIGHLAND CAPITAL MANAGEMENT LP 17,000$100,0000.00%
ALPS ADVISORS INC 46,468$274,0000.00%
Renaissance Technologies 181,900$1,104,0000.00%
View complete list of FORWARD PHARMA A/S shareholders